ICONIC LABS PLC

Share Issue/Capital Change • Dec 31, 2025

National Storage Mechanism | Additional information

RNS Number : 3303N

Iconic Labs PLC

31 December 2025

31 December 2025

Iconic Labs Plc

("Iconic" or the "Company")

Result of AGM

The Directors of Iconic Labs Plc are pleased to announce that at the Annual General Meeting of the Company held earlier today, Resolutions 1 to 7 were all were duly approved by shareholders by way of a poll.

The results of the poll were as follows: 

	Resolutions	For	%	Against	%	Withheld
1	To receive and adopt the accounts for the financial year ended 30 June 2025.	1,714,575	99.35%	11,176	0.65%	8,985
2	To re-appoint RPG Chartered Accountants as Auditors.	1,712,111	99.21%	13,640	0.79%	8,985
3	To authorise the Directors to determine the remuneration of the Auditors.	1,710,100	99.21%	13,640	0.79%	10,996
4	To re-appoint Bela Lendvai-Lintner as a Director.	1,680,380	97.45%	43,887	2.55%	10,469
5	To authorise the Directors to allot shares as set out in the Notice of the meeting.	1,680,974	97.56%	42,054	2.44%	11,708
	Special Resolutions:
6	To adopt new Articles of Association	1,686,150	97.82%	37,640	2.18%	10,946
7	To empower the Directors to generally allot relevant equity securities as set out in the Notice of the meeting.	1,681,376	97.57%	41,887	2.43%	11,473

ENDS

For more information, please contact:

Iconic Labs John Farquharson, Chief Executive Officer	via Yellow Jersey PR
AlbR Capital Limited Daniel Harris / David Coffman	Tel: +44 (0) 20 7469 0930
Yellow Jersey PR Charles Goodwin Annabelle Wills	Tel: +44 (0) 20 3004 9512 [email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGWPGQWPUPAGGG